BCR-ABL tyrosine kinase inhibitors

400 SL SL Pill - orange oval

Generic Name: imatinib

Pill with imprint 400 SL SL is Orange, Oval and has been identified as Gleevec 400 mg. It is supplied by Novartis Pharmaceuticals.

Gleevec is used in the treatment of Chronic Myelogenous Leukemia; Chronic Eosinophilic Leukemia; Dermatofibrosarcoma Protuberans; Acute Lymphoblastic Leukemia; Gastrointestinal Stromal Tumor and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Gleevec 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Gleevec (Imatinib)-400 SL SL-400 mg-Orange-Oval
Gleevec (Imatinib)-400 SL SL-400 mg-Orange-Oval
Gleevec (Imatinib)-400 SL SL-400 mg-Orange-Oval
Gleevec (Imatinib)-400 SL SL-400 mg-Orange-Oval

Gleevec
Generic Name: imatinib
Imprint: 400 SL SL
Strength: 400 mg
Color: Orange
Size: N/A
Shape: Oval
Availability: Prescription only
Drug Class: BCR-ABL tyrosine kinase inhibitors
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00078-0402 (Discontinued)
Inactive Ingredients:
Latest News
Related Drugs